Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07302802Recruiting

Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice

Role: lead

NCT02062164Active Not Recruiting

Weight Loss Surgery in Adolescents With Extreme Obesity

Role: lead

NCT01662271Completed

Course of Obesity and Extreme Obesity in Adolescents

Role: lead

NCT01703273Not ApplicableCompleted

Low-level Intervention for Adolescents With Extreme Obesity

Role: lead

NCT01625325Completed

Identification and Characterization of Youth With Extreme Obesity

Role: lead

All 5 trials loaded